Table 2.
Prevalence of HIV, hepatitis and co-infections in PWID in two urban settings in Mozambique, 2013–2014
Characteristics | PWID Study Population | ||
---|---|---|---|
n | % unweighted | RDS-weighted % (95%CI) | |
HIV infected (N = 445a) | 204 | 45.8 | 44.9 (37.6–52.3) |
HBV infected (N = 490a) | 164 | 33.5 | 32.8 (26.3–39.5) |
HCV infected (N = 446a) | 163 | 36.5 | 38.3 (30.6–45.9) |
HIV/HBV co-infection (N = 444a) | 59 | 13.3 | 13.1 (7.2–18.9) |
HIV/HCV co-infection (N = 424a) | 124 | 29.2 | 29.5 (22.2–36.8) |
HIV/HBV/HCV co-infection (N = 423a) | 40 | 9.5 | 9.2 (3.7–14.7) |
a Denominator reflects the number of participants who consented to testing for each biomarker